(4-Methyl-piperazine-1-yl)-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-phenyl]-methanone, 97.0%, 10g

4,4-DIMETHYLOXAZOLIDINE, 95%, 1g

2-(3-Fluoro-4-nitrophenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 97%, 5g

2-amino-N-(2,5-dimethylphenyl)benzamide, 95.0%, 1g

4-[2-(2-Fluoro-phenyl)-ethyl]-piperidine, 95.0%, 5g

(S)-3-(3-(Allyloxy)phenyl)-2-((tert-butoxycarbonyl)amino)propanoic acid, 95.0%, 5g

N-?[(11bS)?-?2,?6-?Bis[3,?5-?bis(trifluoromethyl)?phenyl]?-?4-?oxido-dinaphtho[2,?1-?d:1',?2'-?f]?[1,?3,?2]?dioxaphosphepin-?4-?yl]?-?1,?1,?1-?trifluoromethanesulfonamide, 97%, 1g

4-Bromo-1-(cyclohexylmethyl)-1H-pyrazole, 95.0%, 5g

N-(4-Fluorophenyl)benzo[d]thiazol-2-amine, 10mg

(S)-1-(4-(4-Methylthiazol-5-yl)phenyl)ethan-1-amine dihydrochloride, 2.5g

N-methyl-1-(1-methyl-2-piperidinyl)methanamine oxalate (1:2), 95.0%, 5g

1-(9-Ethyl-9H-carbazol-3-yl)-N-(2-methoxybenzyl)methanamine hydrochloride, 98%, 25mg

Methyl 2,3,4-Tri-O-acetyl-b-D-glucuronic Acid Methyl Ester, 98.0%, 1g